Estabrook Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
22,934
+800
+4% +$63.1K 0.24% 65
2025
Q4
$1.82M Sell
22,134
-1,098
-5% -$85.6K 0.27% 63
2025
Q3
$1.74M Sell
23,232
-84
-0.4% -$6.26K 0.25% 67
2025
Q2
$1.73M Sell
23,316
-765
-3% -$53.3K 0.27% 66
2025
Q1
$1.94M Buy
24,081
+380
+2% +$32.7K 0.31% 61
2024
Q4
$1.85M Sell
23,701
-241
-1% -$20.5K 0.29% 67
2024
Q3
$2.25M Hold
23,942
0.34% 62
2024
Q2
$1.87M Buy
23,942
+240
+1% +$19.6K 0.29% 69
2024
Q1
$2.15M Buy
23,702
+9,933
+72% +$826K 0.33% 63
2023
Q4
$1.06M Sell
13,769
-33
-0.2% -$2.31K 0.17% 75
2023
Q3
$939K Buy
13,802
+750
+6% +$54.6K 0.17% 78
2023
Q2
$1.06M Sell
13,052
-12
-0.1% -$958 0.18% 76
2023
Q1
$1.07M Buy
+13,064
New +$933K 0.19% 75

Other funds holding GEHC

Estabrook Capital Management's GEHC Position: Q1 2026 in Review

Estabrook Capital Management increased its GE HealthCare (GEHC) stake by 3.6% in Q1 2026, buying an estimated $63.1K and bringing the position to 22,934 shares worth $1.63M. The position accounts for 0.24% of the portfolio, ranked #65.

Estabrook Capital Management first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.25M in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Estabrook Capital Management held 22,934 shares of GE HealthCare worth $1.63M as of Q1 2026.
  • Estabrook Capital Management bought 800 GE HealthCare shares in Q1 2026, an estimated $63.1K.
  • GE HealthCare made up 0.24% of Estabrook Capital Management's portfolio in Q1 2026, its #65 holding.
  • Estabrook Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Estabrook Capital Management's GE HealthCare position peaked at $2.25M in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.